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REVIEW
COMPLEX WOUNDS
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Complex wound is the term used more recently to group those well-known difficult wounds, either chronic or acute, that challenge
medical and nursing teams. They defy cure using conventional and simple “dressings” therapy and currently have a major
socioeconomic impact. The purpose of this review is to bring these wounds to the attention of the health-care community, suggesting
that they should be treated by multidisciplinary teams in specialized hospital centers. In most cases, surgical treatment is unavoidable,
because the extent of skin and subcutaneous tissue loss requires reconstruction with grafts and flaps. New technologies, such as
the negative pressure device, should be introduced. A brief review is provided of the major groups of complex wounds—diabetic
wounds, pressure sores, chronic venous ulcers, post-infection soft-tissue gangrenes, and ulcers resulting from vasculitis.
KEYWORDS: Complex wounds. Socioeconomic impact. Surgical treatment. Skin grafting. Skin flaps.
Expectancy of a longer life is recognized as one of ma-
jor contributions afforded by modern civilization; however,
improvement of quality of life has not necessarily followed
that increase in life years. On the contrary, older
populations may develop problems related to longevity that
can compromise their quality of life.
Losses of cutaneous integument, represented not only
by skin disruption but also by loss of subcutaneous tissues,
sometimes including even muscle and bone, have been gen-
erally defined in medical textbooks as “wounds”. There are
striking differences between simple wounds, for example
surgical wounds or skin scratches, and those chronic
wounds that do not heal primarily and demand specialized
care, mostly in hospitals. However, the latter have not mer-
ited enough attention by surgeons who consider the treat-
ment of wounds to be a less sophisticated aspect of the pro-
fession, and consequently of no special interest.
More recently, the increasing number of aged patients
and the frequency of these more difficult wounds has started
to attract the attention not only of doctors and nurses but
also of health-care administrators worried about the impact
of the cost of these wounds on their hospital budgets.
In Brazil, the topic has not attained widespread inter-
est, but in the State of São Paulo and in particular in Hos-
pital das Clínicas of São Paulo University Medical College,
the problem is gaining more importance in this new cen-
tury.
A proposal was made by a group working at the Divi-
sion of Plastic Surgery of the Institution to form a
multidisciplinary group including doctors (plastic and vas-
cular surgeons, dermatologists) and wound therapy nurses.1
It was formally approved in 2006, and its main goal is the
study of the so-called “complex wounds”.
But what are complex wounds?
There is not as yet a clear definition of complex wounds
or specific criteria to separate them from the simpler ones.
The term “chronic wounds”, although frequently used,
means only that more time was needed up to the cure, but
it is not good enough a concept to characterize the com-
plexity of the problem. We could use “difficult wounds”
(in Portuguese, feridas difíceis), as proposed in German,
(schwierige Wunde), but we prefer to use the term “com-
plex wounds” (feridas complexas) in order to encompass
the different criteria for classifying these special wounds
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and the challenge they pose for medical and nursing teams.
One or more of the following conditions must be present
for a wound to be categorized as a “complex” type:
1 – Extensive loss of the integument is an important crite-
rion, whether it is an acute or chronic wound. Chronic
wounds are defined as wounds that have not healed
expontaneously in 3 months2 and usually have a com-
mon pattern of the complexity.
2 – Infection is frequently present as a complication in
chronic wounds and in itself may be the cause of the
problem that resulted in tissue loss, as happens in ag-
gressive infections like Fournier’s gangrene.
3 – Compromised viability of superficial tissues—clear
necrosis, or signs of circulation impairment either lo-
calized or more extensive, usually in the limbs, lead-
ing to extensive loss of substance.
4 –Association with systemic pathologies that impair nor-
mal healing causing wounds to fail to heal with simple
care and requiring special attention. Feet ulcers in dia-
betic patients and many forms of vasculitis are com-
mon examples.
We thus consider the most commonly seen complex
wounds, needing special care by a specialized group, as the
following:
1 – Wounds in the lower extremity of diabetic patients,
2 – Pressure ulcers,
3 – Chronic venous ulcers,
4 – Wounds following extensive necrotic processes
caused by infections (Fournier’s and other), and
5 – Chronic wounds related to vasculitis and immuno-
suppressive therapy that have not healed using sim-
ple care.
Burns might be included in this group of complex
wounds (and indeed they are, in many instances, very com-
plex wounds), but tradionally they are separated from this
group, basically because burns have been regarded for some
time to be a special condition that should be treated in spe-
cialized burn centers.
Using these concepts, over the last 5 years we have es-
tablished measures to ensure a better understanding of the
prevalence of these complex wounds in our institution (in-
cluding the establishment of an electronic database) and
to study and revise the procedures usually used to treat
them, ie, dressings, surgical options, and new technologies
that have recently become available, such as the negative
pressure on wounds (vacuum systems).
It has already become clear to us that these complex
wounds should usually be treated using surgical procedures
instead of leaving them to clinical and expectant measures.
Additionally, débridements, skin grafting, and flap coverage
should be indicated sooner than has been done traditionally.
Determining that the majority of these complex wounds
should be considered “surgical cases” and not just “cases
for dressings” surely represents the major turning point of
a new policy to provide more stable coverage of the
wounds, thus improving the quality of life. It should re-
duce the time of hospitalization and the cost of treatment.
Preventative measures are also essential.
Complex wounds will be briefly reviewed, and main
factors of policies that will produce faster and stable clo-
sure of these wounds—awareness of the importance for the
health-care system, complexity of the treatment, and cur-
rent best surgical approaches—will be emphasized.
Wounds in diabetic patients
It is well known that diabetes mellitus is a chronic multi-
factorial disease. Global prevalence of diabetes was 120 mil-
lion in 1996, but predictions for 2030 suggests values as high
as 366 million, due to longer life expectancies, obesity, and
sedentary life styles.3,4,5 In Brazil, the diabetic population is
estimated to be approsimately 10 million.6 In 2001, persons
throughout Brazil who were 40 years old or older were in-
vited to participate in community screening for diabetes as
part of the Brazilian Ministry of Health’s Plan for the Reor-
ganization of Care for Arterial Hypertension and Diabetes
Mellitus. Of the 30.2 million persons in the target population,
22.1 million (73.0%) were examined, and 3.5 million tested
(15.7%) positive for elevated blood glucose levels.7
Among the complications that most frequently affect the
diabetic individual are cardio-, retino-, and nephropathies;
however, wounds in the lower extremity also are a major
burden for the patient and health system.8,9,10
Such wounds are usually chronic, mostly in the feet,
and treatment is difficult; all too often, these wounds do
not heal primarily.11,12 Simple control of glucose blood lev-
els, although important, is not necessarily followed by heal-
ing these ulcers.13,14 Frequently, wounds evolve with exten-
sive necrosis and infectious processes that may lead to am-
putation of body parts, even of limbs.15,16,17,18
Obstruction of major blood vessels is responsible for
less that 30% of the wounds; today, the main recognized
cause is the neuropathy of diabetes,19,20,21 the progressive
degeneration of the sensitive nerves of the foot induced by
microangiopathy of the small vessels to the nerve fascicles
and in many cases associated with external compression
at some anatomical sites, as in the tarsal tunnel.22,23,24
Patients develop a progressive loss of sensation on their
lower extremities, and because of that, they do not perceive
small traumas on their feet, resulting in a chronic ulcer with
a lower potential for healing due to the microangiopathic
disease.25,26,27
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Modern treatment of this pathology includes evaluation
not only of the vascular status,28,29,30 but also of the neu-
ropathy, using more precise tests to assess the sensibility
of the feet,31 such as the PSSD™(Pressure Specified Sen-
sory Device) described by Lee Dellon of Baltimore32; in
use at the Hospital das Clínicas.33
This wound should be treated surgically and as soon as
possible, removing necrotic tissues34,35,36 and providing
wound bed preparation37,38 using specific dressings39,40 or
negative pressure41,42,43 (vacuum devices). Closure should be
achieved as soon as possible with skin grafting,44,45,46 local
flaps,47,48,49,50 or microsurgical flaps.51,52,53
With these measures, we expect to reduce the signifi-
cant personal and economic costs caused by the “diabetic
foot”—the resulting longer stay in hospital, longer reha-
bilitation, and need for special care. Amputations should
be avoided at all costs, as they are no longer the only al-
ternative for treatment of the ulcer after failure of conserva-
tive measures to heal the ulcer, even if associated with com-
plications like osteomyelits.54,55
Primary healing in the USA is estimated to cost between
US$ 7,000 and US$10,000 per person, but the overall cost
of an amputation related to the diabetic foot is estimated
between 4.6 and 13.7 billion dollars.56
Costs in Brazil for the treatment of these patients are
not known, but due to the notorious deficiencies in our
health system, they must be very high, and worse, they sig-
nify a major burden for patients and their families.
Pressure sores
Many patients today need a long period of hospitaliza-
tion for the treatment of chronic illnesses; typically they
are old and have limitations in their normal movements.
In this context, we come across pressure wounds, also
known as pressure sores which represent a significant chal-
lenge for health professionals.57,58
A pressure sore is defined as an area of necrosis in the
integument developed as a result of compression of soft tis-
sues between an osseous prominence and a hard surface
during a sufficiently long period of time to induce local
ischemia.59
Patients with pressure sores have extended dependency
on their caretakers, higher mortality, and lower quality of
life. Pressure sores increase hospitalization time and the
overall cost of treatment.60
Accordingly to the National Pressure Ulcer Advisory
Panel, a US agency that coordinates actions for prevention
and treatment of pressure sores, prevalence in hospitals in
the USA varies from 3% to 14%, increasing to 15% to 25%
in nursing homes.61 The incidence reported by Bergstrom
et al62 in home care was 23.9%. In a study performed by
São Paulo University at its Hospital Universitário, the in-
cidence was 39.5% in surgical units, but higher, 41%, in
intensive care units.63
The incidence and prevalence of pressure sores has
grown due to the increase in patient age and lower mortal-
ity in high-complexity surgeries. It is our impression that
in São Paulo it has also grown due to a decrease in the qual-
ity of care and prevention, especially in intensive care units.
Although the problem of diabetic wounds is very ex-
tensive but not well quantified in Brazil, the problem
caused by excessive pressure sores in bedridden patients
should be simpler to evaluate, and measures to identify the
potential cases for developing pressure sores should be put
in practice, especially because we know that these preventa-
tive procedures are most important in the overall care of
the patients.
Unfortunately, policies for preventative measures to
avoid the development of complex wounds have not been
implemented in Brazil, and we are seeing more and more
cases in our hospitals, in addition to many recurrences of
already treated ulcers.
Hospital das Clínicas comprises for Institutes, the larg-
est being the Central Institute, with 920 beds. On average
we have 40 patients with pressure sores—about 5%, a fig-
ure similar to the international standard. Specific evalua-
tion of the severity of those ulcers is currently being done,
aided by the use of electronic databases.
Our proposal is to treat such cases as they are identi-
fied, but to also take into account that the treatment should
more prompt than that in the conventional expectant ori-
entation. Surgical treatment is the main option, and includes
debridement of necrotic tissues, use of negative pressure64
(vacuum) to better prepare the wound bed, and providing
definite closure with stable transplants, mostly local, well-
vascularized transplants.65
Prevention must be enforced using well-known scale
protocols already reported. The Braden scale is the most
popular in our hospitals, and it has been translated into Por-
tuguese.66 These protocols are very important for preven-
tion of ulcers in higher-risk patients, but even after the clo-
sure of the sore, rehabilitation should be instituted in or-
der to prevent recurrences.
Chronic venous ulcers
Described by Hippocrates more than 2,000 years ago,67
chronic venous ulceration is not generally considered a
“curable” disease. Venous stasis ulceration is a frequent
clinical condition causing considerable morbidity, poor
quality of life,68 and significant socioeconomic loss.69
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Chronic venous ulcers are considered to be the most
common disorder of vascular origin.70,71 The chronic ulcer
is caused by chronic venous insufficiency in the lower ex-
tremity, but it is frequently aggravated by scarring proc-
esses in the surrounding skin and subcutaneous tissues that
render treatment of the ulcer by conventional measures slow
and that leave tissues prone to recurrences.72
Definite treatment of venous insuffiency is not possi-
ble with the presently available technology.73,74,75 Measures
to alleviate the insuffiency should be performed when in-
dicated; but in order to solve the problem of the chronic
wound, a more aggressive surgical protocol should aim to
remove the lipodermatosclerotic tissues and to reconstruct
the area with tissues that could bring venous channels to
alleviate the stasis.76,77,78,79
Venous ulcers are frequent, approximately 0.06% to
1.5% nationally and and internationally.80,81,82 The problem
is universally severe, and there is a considerable economic
impact.83,84
The etiology and pathophysiology of chronic venous
ulcers are still incompletely understood. The most common
treatment options include prolonged bed rest, Unna’s boot,85
local wound care,86,87,88 and skin grafting.89,90 We are evalu-
ating modern dressings that can be used for this condition
and prevent complications.91
The importance of the role of skin grafting resilience
and its potential to prevent recurrence is being evaluated,
as is that of local and distant flaps used in more severe
cases of recalcitrant ulcers after removal of the
lipodermatosclerotic tissues.92,93
Vein stripping and perforator ligation valvuloplasty may
improve regional venous hemodynamics and are often in-
dicated by vascular surgeons, but they do not solve the
problem of the wound if there is irreversible scarring due
to surrounding lipodermatosclerosis.
For these reasons, we have categorized chronic venous
ulcers as complex wounds in order to study dressings and
other new ways to treat these wounds as well as the rel-
evance of some surgical procedures being developed in the
USA, including the use of new local flaps and even micro-
surgical transplants to more permanently close the difficult
wounds.68
Extensive necrotic gangrene as in Fournier’s syndrome
Fournier’s gangrene is an infectious necrotizing fasciitis
of the perineum and genital regions caused by a mixture
of aerobic and anaerobic organisms. The mortality rate from
this infection ranges from 0% to 67%.94 The outcome is
usually fatal if there is no early recognition and extensive
surgical debridement upon initial diagnosis.95 This should
be followed by aggressive antibiotic therapy combined with
other precautionary and resuscitative measures. It is well
know that early aggressive surgical debridement combined
with broad-spectrum antibiotic coverage results in de-
creased mortality from Fournier’s gangrene and other forms
of extensive necrotic fasciitis.
Fournier’s gangrene occurs in male and female patients
with genital abscesses, cellulitis, necrotizing fasciitis, and
vascular disorders; it is more frequent in males than in fe-
males.92
Precautionary measures are important for supporting the
patient with Fournier’s gangrene as are urinary and fecal
diversions when necessary. Treatment with hyperbaric oxy-
gen is still controversial as a complementary treatment to
débridements, although some have claimed advantages with
its use.96
In the Hospital das Clínicas, São Paulo, aggressive
débridements have been used for more than 15 years, and
the mortality rate has declined impressively.97,98
However, there are not many articles related to the re-
construction after the removal of skin and subcutaneous tis-
sue that sometimes are quite extensive, and the wound is
usually not amenable to direct closure.
In order to reduce the hospitalization time, we operate
to reconstruct these patients promptly, use negative pres-
sure (vacuum) for faster preparation of the wound bed, and
use skin grafting to close the wound.
Later, reconstruction using flaps for functional (cover-
age of testicles) and for aesthetic proposes are done at un-
der ambulatory conditions.
Wounds in patients with autoimmune disease or under
immunosuppressive drug therapy—vasculitis
Wounds in patients with severe systemic chronic dis-
eases seem to have risen in number as hospital care for
these diseases has improved. Extensive ulcers that could
be considered complex wounds are not frequent, but they
may be an important cause for longer hospitalization time
and for rising costs of treatment; consequently, they need
special consideration.
We have seen a number of those wounds related to
autoimmune diseases such as in rheumatoid arthritis and
related to immunosuppressive drugs, mostly in transplant
patients, and even in less known entities such as pyoderma
gangrenosum. The common pathophysiologic link seems
to be some form of “vasculitis”, which acts in the periph-
eral vessels of the superficial tissues and leads to an in-
flammatory process, capillary occlusion, and necrosis of
tissues.99
The necrotic area is sometimes not well defined, and
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sometimes the surgical debridement can induce new areas
of inflammatory process that enlarge the area.
Corticosteroids may have a positive effect in controlling
the basic problem of vasculitis. Its well-known negative in-
fluence on wound healing seems to be less important if a
reconstructive procedure like a flap or graft is used.
Recent studies on reconstructive surgery for
immunosuppressed organ transplantation patients have shown
that no serious deficit of healing was observed, which was also
observed with reconstruction after tumor removal and chemo-
therapy.100 There is clear evidence that such wounds should
not be treated conservatively but rather included in this group
of complex wounds and treated accordingly in wound centers.
Pyoderma gangrenosum, a cutaneous ulcer with no clear
etiology, represents well the difficulties of treating these
special wounds caused by vasculitis. It can have different
clinical presentations and is often associated with inflam-
matory intestinal disease (55%) and rheumatoid arthritis
(37%).101 It can be associated with plastic surgeries includ-
ing aesthetic ones, particularly in the breast.102
Our experience is not extensive enough to draw any con-
clusion about the best treatment available, but apart of the
appropriate medical systemic treatment for the general con-
dition, the wound should be treated by removal of necrotic
tissue and surrounding tissue of doubtful viability, prepa-
ration of the bed, and closure as soon as possible with skin
grafting techniques.
Use of adjunctive therapies, such as hyperbaric oxygen
therapy, has not proven its value, and it is not presently
recommended by our group.
Multidisciplinary care of the patient is essential.103
RESUMO
Ferreira MC, Tuma Jr. P, Carvalho VF , Kamamoto F.
Feridas complexas. Clinics. 2006;61(6):571-8.
Ferida complexa é uma nova definição para identificar
aquelas feridas crônicas e algumas agudas já bem
conhecidas e que desafiam equipes médicas e de
enfermagem. São difíceis de serem resolvidas usando
tratamentos convencionais e simples curativos. Têm
atualmente grande impacto sócio-econômico. Esta revisão
procura atrair atenção da comunidade de profissionais de
saúde para estas feridas, sugerindo que devam ser tratadas
por equipe multidisciplinar em centro hospitalar
especializado. Na maioria dos casos o tratamento cirúrgico
deve ser indicado, uma vez que a perda de pele e tecido
subcutâneo é extensa, necessitando de reconstrução com
enxertos e retalhos. Nova tecnologia, como uso da terapia
por pressão negativa foi introduzido. Breves comentários
sobre os principais grupos de feridas complexas: pé
diabético, úlceras por pressão, úlceras venosas, síndrome
de Fournier e vasculites.
UNITERMOS: Feridas complexas. Impacto sócio-
econômico. Tratamento cirúrgico. Enxertos de pele.
Retalhos cutâneos.
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